ERα is a major determinant of tumor growth in about 80% of breast cancers in which it controls cell cycle genes such as cyclin D1 (CCND1) and differentiation genes such as the progesterone receptor gene (PGR) and the ERα coding gene itself (ESR1). Here, CCND1 is linked to breast carcinoma.